[Research Progress of Fibroblast Growth Factor Receptor Signaling Pathway in Breast Cancer].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
; 44(1): 136-141, 2022 Feb.
Article
en Zh
| MEDLINE
| ID: mdl-35300776
ABSTRACT
Breast cancer,one of the common malignant tumors in women,has shown rising incidence in recent years,posing a serious threat to women's health.The advancement of molecular biology facilitates the revealing of the relationships between signaling pathways and breast cancer.Fibroblast growth factor receptor (FGFR) signaling pathway plays an important role in the proliferation,survival,differentiation,migration,and apoptosis of breast cancer cells.Strategies targeting the FGFR signaling pathway thus exhibit a promising prospect in breast cancer treatment.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Neoplasias de la Mama
/
Receptores de Factores de Crecimiento de Fibroblastos
Límite:
Female
/
Humans
Idioma:
Zh
Revista:
Zhongguo Yi Xue Ke Xue Yuan Xue Bao
Año:
2022
Tipo del documento:
Article
País de afiliación:
China